InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,473.23
(
0.77%
)
US TECH 100
19,448.00
(
0.24%
)
Dow Jones
38,778.10
(
0.49%
)
Brent Oil
83.65
(
-0.30%
)
Bitcoin
65,464.60
(
-1.54%
)
Post# of 252233
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

oc631

Send PM Follow Ignore
Followers 15
Posts 1749
Boards Moderated 0
Alias Born 08/12/2007

oc631

Re: genisi post# 156463

Tuesday, 02/05/2013 11:19:29 AM

Tuesday, February 05, 2013 11:19:29 AM

Post# of 252233
The possibility of ribavirin resistance when used without interferon could be a factor. There's also a moral hazard issue to the FDA approving a combo that works in half the patients and GILD profiting twice upon retreatment. There's no competition in these genotypes.
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up